Consumption of Ultra-Processed Foods Tied to Upper Digestive Tract Cancers
By Lori Solomon HealthDay Reporter
FRIDAY, Dec. 22, 2023 -- Higher ultra-processed food (UPF) consumption is associated with a greater risk for head and neck cancer (HNC) and esophageal adenocarcinoma (OAC), according to a study published online Nov. 22 in the European Journal of Nutrition.
Fernanda Morales-Berstein, from the University of Bristol in the United Kingdom, and colleagues investigated the role of adiposity in the associations between UPF consumption and HNC and OAC. The analysis included 450,111 participants in the European Prospective Investigation into Cancer and Nutrition cohort.
The researchers found that during a mean follow-up of 14.13 years, a 10 percent g/day higher consumption of UPFs was associated with an increased risk for HNC (hazard ratio, 1.23) and OAC (hazard ratio, 1.24). Five percent of the association with HNC was mediated by waist-to-hip ratio (WHR), while body mass index mediated 13 percent and WHR mediated 15 percent of the association between the consumption of UPFs and OAC risk. There was a positive association seen between UPF consumption and accidental death in the negative control analysis.
"Focusing solely on weight loss treatment, such as semaglutide, is unlikely to greatly contribute to the prevention of upper-aerodigestive tract cancers related to eating UPFs," Morales-Berstein said in a statement.
One author disclosed ties to the pharmaceutical industry.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
Source: HealthDay
Posted : 2023-12-23 02:15
Read more
- Gene Therapy Might Tweak Fats, Help Prevent Arthritis in Overweight Kids
- ACG: Fewer Overt Hepatic Encephalopathy Episodes Seen With Rifaximin
- Prepping for Colonoscopy? An Expert Offers Tips to Make Things Easier
- Women Can Incur 'Catastrophic' Bills for Out-of-State Abortions, Study Finds
- Men Aged >16 to
- Substantial Mortality Benefits Expected From Optimal Medication Use for HFrEF
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions